Eris Lifesciences acquires Oaknet Healthcare

04 May 2022 Evaluate

Eris Lifesciences has acquired Mumbai-based dermatology-focused domestic formulations company Oaknet Healthcare for Rs 650 crore. The acquisition will be completed by way of a share purchase agreement and accordingly Oaknet will become a wholly-owned subsidiary of Eris. The deal will be financed by Rs 300 crore internal accruals and Rs 350 crore by borrowings.

Eris Lifesciences is the only publicly listed Indian pharmaceutical company with a pure-play domestic branded formulations business model.

Eris Lifesciences Share Price

1410.90 21.20 (1.53%)
19-Dec-2024 11:34 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1809.60
Dr. Reddys Lab 1325.45
Cipla 1489.60
Lupin 2118.40
Zydus Lifesciences 987.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.